Clinical Trials Logo
  1. Home
  2. Keratosis, Actinic
  3. NCT04269395

A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study

Keratosis, Actinic Clinical Trial

Official title:
A Double-blind, Multicenter, Long-term Follow-up Study to Assess Recurrence of Actinic Keratosis in Subjects Treated With Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream (CD06809-41) or Vehicle Cream in the Treatment of Thin and Moderately Thick, Non-hyperkeratotic, Non-pigmented Actinic Keratosis of the Face and Scalp When Using Daylight Photodynamic Therapy (DL-PDT), for Subjects Achieving Complete Response of Treated Lesions at Final Visit in Study RD.06.SPR.112199

Clinical Trial Summary

The primary purpose for this study is to assess recurrence of Actinic Keratosis in participants achieving complete response treated in earlier study.

Clinical Trial Description

This is a double-blind, multicenter, long-term follow-up study. The primary purpose of this study is to assess recurrence of Actinic Keratosis in participants treated with Methyl aminolevulinate hydrochloride (MAL) 16.8 percent (%) cream (CD06809-41) or vehicle cream in the treatment of thin and moderately thick, non-hyperkeratotic, non-pigmented actinic keratosis of the face and scalp when using daylight photodynamic therapy (DL-PDT), for participants achieving complete response of treated lesions at Final Visit in Study RD.06.SPR.112199 (NCT04085367). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04269395
Study type Interventional
Source Galderma R&D
Contact
Status Terminated
Phase Phase 3
Start date April 7, 2020
Completion date September 1, 2021
View Details
See also
  Status Clinical Trial Phase
Completed NCT03076892 - Evaluation of Non-inferiority and Tolerability of the Device PHOS-ISTOS N/A
Terminated NCT03076918 - Evaluating the Device FLEXITHERALIGHT Compared to the Conventional Photodynamic Therapy N/A
Completed NCT05356572 - A Pre-market Study to Evaluate the Performance and Safety of a Skin Preparation Device for Removal of Dry Crusty Skin N/A
Recruiting NCT05387525 - A Study of Tirbanibulin Ointment and Diclofenac Sodium Gel for the Treatment of Adult Participants With Actinic Keratosis on the Face or Scalp Phase 4
Completed NCT02594644 - The Use of Microneedles to Expedite Treatment Time in Photodynamic Therapy N/A
Active, not recruiting NCT02281682 - IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic Keratosis Phase 4
Completed NCT01458587 - Levulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK) Phase 2
Completed NCT05260073 - Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis
Active, not recruiting NCT06014697 - OCT and Invasion in Cutaneous Skin Lesions
Completed NCT05279131 - A Study to Evaluate the Safety and Tolerability of Tirbanibulin Ointment 1% in Adult Participants With Actinic Keratosis Phase 3
Completed NCT05481073 - UV Sensor in Patients With Actinic Keratosis
Completed NCT03697590 - Photodynamic Therapy of Actinic Keratosis of the Face and Scalp With and Without Prior Curettage Phase 4
Withdrawn NCT02813902 - A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its Precursors Phase 1
Recruiting NCT05636800 - Microwave Treatment for Actinic Keratosis N/A
Completed NCT02628236 - Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2) Phase 2
Recruiting NCT06135415 - A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic Keratosis Phase 3
Completed NCT02644187 - Pain Relief During Photodynamic Therapy for Actinic Keratoses With a New Irradiation Protocol N/A
Completed NCT02281136 - MUSE Study of Levulan Kerastick Phase 2
Completed NCT05060237 - Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp Phase 1